Publicacions en què col·labora amb Miguel Ángel Piris Pinilla (8)

2012

  1. Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: Development and validation on 593 cases

    British Journal of Haematology, Vol. 159, Núm. 2, pp. 164-171

2004

  1. Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFκB transcription factors

    Journal of Pathology, Vol. 204, Núm. 5, pp. 528-537

  2. Influence of biologic markers on the outcome of Hodgkin's lymphoma: A study by the Spanish Hodgkin's Lymphoma Study Group

    Journal of Clinical Oncology, Vol. 22, Núm. 9, pp. 1664-1673

2000

  1. Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy

    Leukemia and Lymphoma, Vol. 39, Núm. 5-6, pp. 563-572

1999

  1. Other cancers in patients with gastric MALT lymphoma

    Leukemia and Lymphoma, Vol. 33, Núm. 1-2, pp. 161-168

1997

  1. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr Virus-latent membrane protein 1 expression

    Blood, Vol. 90, Núm. 6, pp. 2429-2436

1996

  1. Evaluation of the international index in the prognosis of high grade gastric malt lymphoma

    Leukemia and Lymphoma, Vol. 24, Núm. 1-2, pp. 159-163

1995

  1. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients

    Annals of Oncology, Vol. 6, Núm. 4, pp. 355-362